How people get it: By prescription. Some doctors prescribe it off-label for aging.
Part of Age reversal: drugs and supplements studied for slowing aging
The basics
What it is
Metformin belongs to a class of drugs called biguanides. It comes as a tablet, a long-acting tablet, and a liquid taken by mouth.
Source: MedlinePlus (NIH): Metformin: MedlinePlus Drug Information ↗
How it's thought to work
Metformin lowers the sugar absorbed from food and the sugar made by the liver. It also makes the body respond better to insulin, a natural substance that controls blood sugar.
Source: MedlinePlus (NIH): Metformin: MedlinePlus Drug Information ↗
What people use it for
- It is often the first diabetes pill that health care providers prescribe for type 2 diabetes.
- Metformin is not used to treat type 1 diabetes.
- It may be combined with another medicine if blood sugar is not in range after 3 months.
- It controls diabetes but does not cure it.
- Metformin may help improve cholesterol levels and help people with diabetes lose some weight.
Sources: MedlinePlus (NIH): Type 2 diabetes - oral medicines: MedlinePlus Medical Encyclopedia ↗ · MedlinePlus (NIH): Metformin: MedlinePlus Drug Information ↗
What the research has found so far
Studied for aging mostly through observational data. A large aging trial has been proposed.
On Metformin and aging, PubMed lists 32 trials in people, 71 studies that watched people over time, 277 animal and lab studies. See the counts and searches
Stage 4 because it is FDA-approved to lower blood sugar in type 2 diabetes. See the source ↗
A stage shows how far research has got, not whether it will work for you. How stages work
Side effects and risks
- Listed side effects include diarrhea, nausea, stomach discomfort, gas, indigestion, and constipation.
- Other listed side effects include weakness, taste change, headache, skin flushing, nail changes, muscle pain, and rash.
- The most common side effect is diarrhea.
- People taking metformin sometimes become low in vitamin B12.
- It has a low risk of low blood sugar.
- Metformin may cause changes in blood sugar.
- People on the extended-release tablets may see an empty tablet shell in their stool, which does not mean the dose was missed.
Sources: MedlinePlus (NIH): Metformin: MedlinePlus Drug Information ↗ · MedlinePlus (NIH): Type 2 diabetes - oral medicines: MedlinePlus Medical Encyclopedia ↗
Who should be careful, and drug interactions
- The page says to tell a doctor about kidney disease, and that the doctor will probably say not to take metformin.
- Before surgery or dye x-ray procedures, metformin may need to be stopped and restarted after at least 48 hours.
- Drinking alcohol raises the risk of lactic acidosis or may lower blood sugar.
- People with liver or kidney disease or heavy drinkers should not take metformin, according to this page.
Sources: MedlinePlus (NIH): Metformin: MedlinePlus Drug Information ↗ · MedlinePlus (NIH): Type 2 diabetes - oral medicines: MedlinePlus Medical Encyclopedia ↗
Approval and legal status
Amounts used in studies
What studies or labels describe, not a recommendation.
- The label-style information lists the regular tablet as usually taken with meals two or three times a day.
- The extended-release tablet is usually taken once daily with the evening meal.
- The liquid is usually taken with meals one or two times a day.
- Doctors may start with a low dose and raise it no more often than every 1–2 weeks.
Source: MedlinePlus (NIH): Metformin: MedlinePlus Drug Information ↗
Roughly what it costs
We don't have prices for this yet.
Questions to ask your doctor
- Is Metformin a sensible option for me, given my health and the medicines I take?
- Could Metformin interact with any medicine or supplement I already take?
- What side effects should I watch for, and when should I stop or call you?
- Would Metformin be used for its approved purpose, or off-label for aging?
- How would we tell whether it is helping, and when should we review it?
This is general information gathered from the sources listed, not medical advice. Talk to your doctor before starting anything new.
TAME led by the American Federation for Aging Research
Targeting Aging with Metformin: a planned six-year trial in about 14 medical centers, giving healthy people aged 65 to 80 either metformin or a placebo, to test whether a drug can slow aging itself rather than one disease. The FDA approves drugs only for recognized diseases, and aging isn't one, so the trial is also meant as a test case for that. It is not registered on ClinicalTrials.gov yet, and AFAR is raising money to launch it. AFAR: NPR spotlights the TAME Trial ↗
Not yet started: AFAR is still raising money to launch it.
“AFAR is leading fundraising efforts to support and launch the TAME Trial.” AFAR ↗
Not yet knownWhether metformin slows aging in people without diabetes. Trials so far have been small or measured other things; see the metformin research above.
What experts say
“TAME is not a moonshot. It’s not even about scientific achievement really, it’s more about political achievement. Metformin is a tool to get aging as an indication.”
“If you could help prevent multiple problems at the same time, like we think metformin may do, then that's almost the ultimate in preventative medicine,”
Report a problem with a quote
What others are writing
Recent articles about Metformin from health journalists, hospitals and universities. We link to them; we don't write or endorse them.
Popular diabetes drug metformin may slow aging, study finds ↗
“A new study finds metformin, a popular diabetes drug that's taken by millions of Americans, may slow aging .”
A study in monkeys found that daily metformin over three years slowed aging of several organs, including the brain.
Cheap longevity drug? Researchers aim to test if metformin can slow down aging ↗
“Metformin costs less than a dollar a day, and depending on insurance, many people pay no out-of-pocket costs for the drug.”
NPR reports that researchers are launching a trial to test whether the cheap diabetes drug metformin can prevent age-related diseases in healthy older adults.
Videos
Talks and interviews that name Metformin, from aging research institutes, scientific meetings, science outlets and longevity companies. We link to them; we don't make or endorse them.
Commentary in journals
Recent research
Three common treatments and their possible links to aging and heart health
This review summarizes earlier studies on metformin, SGLT2 inhibitors, and fasting, and suggests a plan for using them together.
Metformin plus exercise and diet did not improve physical function in older adults with obesity
Researchers randomly assigned older adults with obesity to lifestyle changes, with or without metformin, or diet education with metformin.
Why artery aging may drive heart disease beyond cholesterol
This review pulls together recent and older studies on how aging blood vessels may fuel heart disease.
Metformin slowed frailty and lowered biological age in older adults
In a two-year trial, metformin slowed a frailty index score and lowered two blood-based aging clocks compared with placebo.
Small pilot tests drug and digital tracking for healthy aging in older adults
A small study gave 31 adults in Israel one of two drug mixes for about eight weeks and tracked them with phone-based checks.
Trials
ClinicalTrials.gov lists 65 registered trials that mention Metformin, for any condition (the count in The science below). Here we show the ones about aging. See them all ↗
The science
Counted from PubMed and ClinicalTrials.gov on Oct 30, 2026, using one search for Metformin in relation to aging. Each link opens the exact search.
- Randomized trials in people
- 27 search ↗
- Large trials (multicenter or phase 3)
- 5 search ↗
- Phase 3 trials
- 0 search ↗
- Trials in people
- 32 search ↗
- Studies that watched people over time
- 71 search ↗
- Animal and lab studies
- 277 search ↗
- Registered trials
- 65 search ↗
PubMed search used
metformin[tiab] AND (aging[tiab] OR ageing[tiab] OR longevity[tiab] OR lifespan[tiab] OR "life span"[tiab] OR healthspan[tiab] OR "Aging"[mh] OR "Longevity"[mh])
Counts are search results, so they include some records that only mention Metformin. How we count
Cite or share this page
Longevity Progress. (n.d.). Metformin: Research stage and evidence. Retrieved October 30, 2026, from https://longevityprogress.com/treatments/metformin
<iframe src="https://longevityprogress.com/embed/stage/metformin" title="Metformin: research stage on Longevity Progress" width="340" height="72" style="border:0" loading="lazy"></iframe>
The badge shows this treatment's current research stage and links back here. It updates by itself when the stage changes.
